<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This report summarizes the results of unrelated cord blood transplants </plain></SENT>
<SENT sid="1" pm="."><plain>Sixty-five patients were reported to Eurocord </plain></SENT>
<SENT sid="2" pm="."><plain>One year survival was 29% </plain></SENT>
<SENT sid="3" pm="."><plain>Factors associated with survival were diagnosis, inborn errors had a better survival than <z:hpo ids='HP_0001909'>leukemia</z:hpo> or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>; higher number of cells infused and negative pre-transplant CMV serology were also favorable factors </plain></SENT>
<SENT sid="4" pm="."><plain>Granulocyte and platelet engraftment were associated with a higher number of nucleated cells infused, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GVH</z:e> incidence was low especially in CMV negative patients, it was not associated with the degree of HLA disparity </plain></SENT>
<SENT sid="5" pm="."><plain>These results were similar to other series reported in the USA and showed the benefit of using mismatched unrelated cord blood in clearly defined situations </plain></SENT>
</text></document>